Navigation Links
Testosterone Injections Offer Hope for Male Contraceptive
Date:5/5/2009

Possible alternative to current birth control methods needs more study

TUESDAY, May 5 (HealthDay News) -- Injectable testosterone may be an effective form of male contraception, new research suggests.

Chinese researchers injected 1,045 healthy, fertile Chinese men aged 20 to 45 years with a 500 milligram formulation of testosterone undecanoate in tea seed oil once a month for 30 months.

All of the study participants had a normal medical history and had fathered at least one child within two years of beginning the study. The female partners of the study participants, aged 18 and 38 years, also had normal reproductive function.

Results showed a contraceptive failure rate of 1.1 per 100 men in the 24-month efficacy phase, resulting in pregnancy. The researchers noted that no serious adverse events were reported in any of the men and, in all but two men, reproductive function returned to the normal fertile reference range.

"For couples who cannot, or prefer not to use only female-oriented contraception, options have been limited to vasectomy, condom and withdrawal," said Dr. Yi-Qun Gu, of the National Research Institute for Family Planning in Beijing, China. "Our study shows a male hormonal contraceptive regimen may be a potential, novel and workable alternative."

The study will appear in the June issue of the Journal of Clinical Endocrinology & Metabolism.

This is the largest multi-center, male hormonal contraceptive efficacy clinical trial of an androgen preparation, Gu said in an Endocrine Society news release.

"Despite the present encouraging results, the long-term safety of this hormonal male contraceptive regimen requires more extensive testing with a focus on cardiovascular, prostate and behavioral safety," Gu said.

More information

MaleContraception.org has more on efforts to develop male hormonal contraception, including using testosterone.



-- Jennifer Thomas



SOURCE: The Endocrine Society, news release, May 4, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. 1 in 4 Men Over 30 Has Low Testosterone
2. The latest about male infertility and testosterone from NewYork-Presbyterian/Weill Cornell
3. Low Testosterone Might Shorten Mens Lives
4. Testosterone supplementation for older men appears to have limited benefit
5. MSU research indicates testosterone could guard against eating disorders
6. Older Men With Low Testosterone Face Greater Depression Risk
7. AUDIO from Medialink and Solvay Pharmaceuticals: Men with Type 2 Diabetes at Increased Risk for Low Testosterone Should Talk to Their Doctors
8. Testosterone Therapy May Reduce Bone Loss in Older Men
9. Testosterone Levels Among Financial Traders Affect Performance
10. Testosterone Spray Improves Sexual Satisfaction in Women
11. Many men with low testosterone levels do not receive treatment
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Testosterone Injections Offer Hope for Male Contraceptive
(Date:12/6/2016)... ... December 06, 2016 , ... "Add realistic flares and light leaks to your ... clip to clip with high quality 4K lens flare footage," said Christina Austin - ... flares filmed on the RED Dragon. Utilizing the Dragon Sensor, TransFlare 4K Jewel lens ...
(Date:12/5/2016)... , ... December 05, 2016 , ... What: Shriners Hospitals ... the North Pole to our patients – using a video monitor and web-enabled camera. ... hospital will transform the Auditorium into a Christmas Wonderland, which is where the video ...
(Date:12/5/2016)... ... 05, 2016 , ... Edward Buckingham MD , and ... of the newest Sciton laser in January 2017. The Halo is the first ... ablative wavelengths for exceptional results. Outperforming more traditional lasers, the innovative Halo automatically ...
(Date:12/5/2016)... ... , ... For many years, Andrew G. Zubinas has accumulated over ... of the Lithuanian language and its poetry inspired him in writing “ ... explores all aspects of a living, breathing forest where nothing ever stays the same. ...
(Date:12/5/2016)... ... December 05, 2016 , ... ... relationship-marketing firm, announced today that nominations will be accepted from December 5, ... Central Awards. , Awards include the Information Security Executive® of the Year, ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... PARSIPPANY, N.J. , Dec. 5, 2016 ... today announced preliminary safety and efficacy data from ... oral selective MDM2 inhibitor, suggesting that DS-3032 may ... relapsed/refractory acute myeloid leukemia (AML) and high-risk myelodysplastic ... part of the phase 1 study of DS-3032 were ...
(Date:12/5/2016)... , Dec. 5, 2016 Eisai Inc. announced ... the 2016 Annual Meeting of the American Epilepsy Society ... is indicated as an adjunctive therapy for the treatment ... generalized seizures and primary generalized tonic-clonic seizures (PGTC) in ... and older. Please see Important Safety Information for FYCOMPA, ...
(Date:12/5/2016)... BioLineRx Ltd. (NASDAQ/TASE: BLRX), a clinical-stage ... candidates, presents positive Phase 2a correlative data, as well as ... at the ongoing 58th American Society of Hematology (ASH) Annual ... . ... As previously announced, in ...
Breaking Medicine Technology: